Your browser doesn't support javascript.
loading
Saporin, a Polynucleotide-Adenosine Nucleosidase, May Be an Efficacious Therapeutic Agent for SARS-CoV-2 Infection.
Arslan, Idris; Akgul, Hafize; Kara, Murat.
Afiliación
  • Arslan I; Biomedical Engineeing, Bulent Ecevit University, Incivez, Zonguldak, Turkey.
  • Akgul H; Graduate School of Natural and Applied Sciences, Nanotechnology Engineeing, Bulent Ecevit University, Incivez, Zonguldak, Turkey.
  • Kara M; Graduate School of Natural and Applied Sciences, Nanotechnology Engineeing, Bulent Ecevit University, Incivez, Zonguldak, Turkey.
SLAS Discov ; 26(3): 330-335, 2021 03.
Article en En | MEDLINE | ID: mdl-33155515
Saporin, a type I ribosome-inactivating protein from soapwort plant, is a potent protein synthesis inhibitor. Catalytically, saporin is a characteristic N-glycosidase, and it depurinates a specific adenine residue from a universally conserved loop of the major ribosomal RNA (rRNA) of eukaryotic cells. It is well-known that saporin induces apoptosis through different pathways, including ribotoxic stress response, cell signal transduction, genomic DNA fragmentation and RNA abasic lyase (RAlyase) activity, and NAD+ depletion by poly-(ADP)-ribose polymerase hyperactivation. Saporin's high enzymatic activity, high stability, and resistance to conjugation procedures make it a well-suited tool for immunotherapy approaches.In the present study, we focus on saporin-based targeted toxins that may be efficacious therapeutic agents for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Our discussed points suggest that saporin may be a strategic molecule for therapeutic knockout treatments and a powerful candidate for novel drugs in the struggle against coronavirus 2019 (COVID-19).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Saporinas / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: SLAS Discov Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Saporinas / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: SLAS Discov Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos